As recently as last summer, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As new, even more contagious variants of the virus have emerged, however, it has become […]
Read MoreAs I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]
Read MoreThe advent of a new year brings with it the prospect of new challenges and new opportunities to embrace. Whether you are the type to set New Year’s resolutions or not, for most of us turning the calendar from one year to the next usually includes some thought about what’s happened and what’s coming up. […]
Read MoreNew COVID stimulus checks are coming in 2022 to some US workers Almost two years after the start of the pandemic, some of the hardest-hit workers in essential industries are in line for some new federal help for their expenses when they worked through the crisis. Many had to dip into their own pockets to […]
Read MoreAs a conservative-minded, value and fundamental-driven investor, my natural tendency is to shy away from stocks that market experts and popular market media analysts tend to talk to the most about. That means that my investments rarely look very sexy – but I’m far more interested in being able to keep my money working for […]
Read MorePart of taking a smart, value-based approach to investing in the stock market involves keeping track of information on industry and economic trends that are likely to have broad residual impacts on market activity. One of the sectors that I think has a broad carryover effect on multiple other sectors in the economy is Energy, […]
Read MoreThe surging Omicron variant has helped underline the need for booster shots, including perhaps even a fourth jab, as Israel is currently trialing. So why are the stocks of leading COVID-19 vaccine makers tanking? Shares of Moderna have fallen almost 35% in the past month. BioNTech, whose mRNA technology is behind the Pfizer vaccine, has […]
Read MoreOne of the sources of a lot of conversation among talking heads and market analysts in general lies around the “reopening” concept. This theme has been pretty constant for most of the year, even as COVID variants – omicron is just the latest – have extended the health crisis well into 2022, with some experts […]
Read MoreOne of the fairly consistent themes of 2021 has been the impact of the global pandemic on different pockets of the economy. While everybody is anxious to look past the days of social isolation, quarantine and shelter-in-place requirements at the early stages of the crisis, and talk about seeing life get “back to normal,” the […]
Read MoreThe Food Products industry in the Consumer Staples sector is an area of the market that tends to get overlooked because, let’s face it, it just isn’t very sexy. Even so, it is one of very few segments of the market that saw consumer-driven improvements in demand in 2020, especially in the early stages of […]
Read MoreFor investors, the holiday season generally marks a time when consumer activity should be healthy and demand for consumer goods will be high. That’s a big reason that the latter part of the year, as the colder months set in across the country that retail stocks often start to see healthy increases in prices. That […]
Read MoreThis stock with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. FLGT $100.7700 9.4800 % 10.3800 Fulgent Genetics Inc Sector : Medical Industry : Medical Information Systems […]
Read MoreAs wrap up 2021 and look toward 2022, the sad and simple truth is that, no matter how much we might want to be able stop including COVID-19 and its impact on every aspect of life in our daily discussions, the health crisis hasn’t gone away, but instead is showing more persistence than any of […]
Read MoreOver the last three years, I’ve used economic uncertainty – first from a year-long trade war through 2019, and then of course the COVID-19 pandemic starting in 2020 – as the basis for a lot of the analysis, and certainly some of my own investments in the marketplace. I think that when economic conditions become […]
Read MoreFor most of the last two years – even before the pandemic started – one of the areas that I have been able to find some interesting valuations to work with have come from the Telecommunications industry. Some of the largest players in the industry do much more than just telecommunications; AT&T Inc. (T) has, […]
Read More